Mesenchymal Stem Cells (MSC)

Global Market Trajectory & Analytics

MCP-7815

EXECUTIVE ENGAGEMENTS

POOL

2183
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

393
Interactions with Platform & by Email

PARTICIPANTS

66
Unique # Participated

VALIDATIONS

22
Responses Validated*

COMPANIES

56
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

108

PAGES

194

EDITION

19

PRICE

USD 5600

CODE

MCP-7815


COMPETITIVE METRICS

COMPANY

D S N T

% *

Abcam PLC

AdipoSeeds

Aegle Therapeutics

Alloplex Biotherapeutics, Inc.

AlloSource

American Type Culture Collection (ATCC)

Anterogen Co., Ltd.

Athersys, Inc.

Biological Industries Israel Beit-Haemek

Brainstorm Cell Therapeutics, Inc.

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Mesenchymal Stem Cells (MSC) estimated at US$172.9 Million in the year 2020, is projected to reach a revised size of US$229 Million by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Human MSC, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$94.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mouse MSC segment is readjusted to a revised 4% CAGR for the next 7-year period.
The Mesenchymal Stem Cells (MSC) market in the U.S. is estimated at US$50.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$40.6 Million by the year 2027 trailing a CAGR of 3.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.
In the global Rat MSC segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$27.7 Million in the year 2020 will reach a projected size of US$36.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$25.5 Million by the year 2027.

SELECT PLAYERS

Cell Applications Inc.; Celprogen Inc.; Cyagen US Inc.; Genlantis Inc.; Lonza Group; Mesoblast Limited; MilliporeSigma; Neuromics; Orthofix International N.V.; PromoCell GmbH; R&D Systems Inc.; ScienCell Research Laboratories; Stemcell Technologies Inc.; Stemedica Cell Technologies Inc.; Thermo Fischer Scientific Inc.

SEGMENTS

» Type (Human MSC, Mouse MSC, Rat MSC, Other Types) » Application (Research Institutes, Hospitals, Other Applications)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Mesenchymal Stem Cells Market on a Rapid Growth Path
Recent Market Activity
Current and Future Analysis
The Present and Future of MSC Therapies
Select MSC-based Therapeutics
Mesenchymal Stem Cell Research
Completed Phase III Studies with MSCs
MSCs are Being Explored for Several New Treatment Possibilities
Widespread Commercialization of 'Off-the-Shelf' MSCs to Become a Reality
Software Companies Endeavour to Cash in on the Boom
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Cell Applications, Inc. (USA)
Celprogen, Inc. (USA)
Cyagen US Inc. (USA)
Genlantis, Inc. (USA)
Lonza Group (Switzerland)
Mesoblast Limited (Australia)
MilliporeSigma (USA)
Neuromics (USA)
Orthofix International N.V. (Italy)
PromoCell GmbH (Germany)
R&D Systems, Inc. (USA)
ScienCell Research Laboratories (USA)
Stemcell Technologies Inc. (Canada)
Stemedica Cell Technologies, Inc. (USA)
Thermo Fischer Scientific, Inc. (USA)
Vitro Biopharma (USA)
3. MARKET TRENDS & DRIVERS
Development of Regenerative Medicine Accelerates Demand for MSCs
Ageing Demographics to Drive Demand for Mesenchymal Stem Cell Therapies
Global Aging Population Statistics - Opportunity Indicators
Growing Prevalence of Chronic Diseases Propels Demand for Mesenchymal Stem Cells
Key Disease Statistics - Opportunity Indicators
Growing Volume of Orthopedic Procedures: An Opportunity for the MSC Market
Adult Stem Cell Therapies on Growth Trajectory, as Controversies Continue to Haunt Embryonic Stem Cell Research
Adult Stem Cells and Embryonic Stem Cells - A Comparison
MSCs Versus Embryonic or Induced Pluripotent Stem Cells
MSC Therapies - Immune to Ethical Issues Applicable to Embryonic Stem Cells
MSCs - A Potential Vehicle for 'Targeted Drug Delivery'
Stem Cell Based Bone Grafts: Promising Growth Ahead
Loopholes Associated with In Vivo Properties Constrain Therapeutic Advancements
Major Challenges Confronting Mesenchymal Stem Cell Market
Allogeneic MSCs - Offering Promise in Immunosuppressive and Tissue Repair Therapy
Administration Route Determines the Effectiveness of MSCs
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Mesenchymal Stem Cells (MSC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Human MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Human MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Human MSC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Mouse MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Mouse MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Mouse MSC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Rat MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Rat MSC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Rat MSC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
China Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Mesenchymal Stem Cells (MSC) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
France Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Mesenchymal Stem Cells (MSC) by Type - Human MSC, Mouse MSC, Rat MSC and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Type - Percentage Breakdown of Value Sales for Human MSC, Mouse MSC, Rat MSC and Other Types for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Mesenchymal Stem Cells (MSC) by Application - Research Institutes, Hospitals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Mesenchymal Stem Cells (MSC) by Application - Percentage Breakdown of Value Sales for Research Institutes, Hospitals and Other Applications for the Years 2012, 2020 & 2027
Total Companies Profiled: 56

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com